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Lourdes Mateos-Hernández 1, Georg Gerhard Duscher 2, Deepak Kumar Sinha 4,
Wolfgang Hemmer 5, Ines Swoboda 3, Agustín Estrada-Peña 6 and José de la Fuente 7,8*
1UMR BIPAR, INRA, ANSES, Ecole Nationale Vétérinaire d’Alfort, Université Paris-Est, Maisons-Alfort, France, 2Department
of Pathobiology, Institute of Parasitology, University of Veterinary Medicine Vienna, Vienna, Austria, 3Molecular Biotechnology
Section, University of Applied Sciences, Vienna, Austria, 4 Biology Center, Institute of Parasitology, Czech Academy of
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The α-Gal syndrome (AGS) is a type of allergy characterized by an IgE antibody (Ab)
response against the carbohydrate Galα1-3Galβ1-4GlcNAc-R (α-Gal), which is present
in glycoproteins from tick saliva and tissues of non-catarrhine mammals. Recurrent tick
bites induce high levels of anti-α-Gal IgE Abs that mediate delayed hypersensitivity
to consumed red meat products in humans. This was the first evidence that tick
glycoproteins play a major role in allergy development with the potential to cause fatal
delayed anaphylaxis to α-Gal-containing foods and drugs and immediate anaphylaxis to
tick bites. Initially, it was thought that the origin of tick-derived α-Gal was either residual
blood meal mammalian glycoproteins containing α-Gal or tick gut bacteria producing
this glycan. However, recently tick galactosyltransferases were shown to be involved
in α-Gal synthesis with a role in tick and tick-borne pathogen life cycles. The tick-borne
pathogen Anaplasma phagocytophilum increases the level of tick α-Gal, which potentially
increases the risk of developing AGS after a bite by a pathogen-infected tick. Two
mechanisms might explain the production of anti-α-Gal IgE Abs after tick bites. The
first mechanism proposes that the α-Gal antigen on tick salivary proteins is presented
to antigen-presenting cells and B-lymphocytes in the context of Th2 cell-mediated
immunity induced by tick saliva. The second mechanism is based on the possibility
that tick salivary prostaglandin E2 triggers Immunoglobulin class switching to anti-α-Gal
IgE-producing B cells from preexisting mature B cells clones producing anti-α-Gal IgM
and/or IgG. Importantly, blood group antigens influence the capacity of the immune
system to produce anti-α-Gal Abs which in turn impacts individual susceptibility to AGS.
The presence of blood type B reduces the capacity of the immune system to produce
anti-α-Gal Abs, presumably due to tolerance to α-Gal, which is very similar in structure
to blood group B antigen. Therefore, individuals with blood group B and reduced levels
of anti-α-Gal Abs have lower risk to develop AGS. Specific immunity to tick α-Gal is
linked to host immunity to tick bites. Basophil activation and release of histamine have
been implicated in IgE-mediated acquired protective immunity to tick infestations and
chronic itch. Basophil reactivity was also found to be higher in patients with AGS when
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compared to asymptomatic α-Gal sensitized individuals. In addition, host resistance to
tick infestation is associated with resistance to tick-borne pathogen infection. Anti-α-Gal
IgM and IgG Abs protect humans against vector-borne pathogens and blood group B
individuals seem to be more susceptible to vector-borne diseases. The link between
blood groups and anti-α-Gal immunity which in turn affects resistance to vector-borne
pathogens and susceptibility to AGS, suggests a trade-off between susceptibility to AGS
and protection to some infectious diseases. The understanding of the environmental and
molecular drivers of the immune mechanisms involved in AGS is essential to developing
tools for the diagnosis, control, and prevention of this growing health problem.
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INTRODUCTION
Most mammals express the antigen Galα1-3Galβ1-4GlcNAc-
R (α-Gal). Inactivation of the α-1,3-galactosyltransferase
(α1,3GalT) gene in old world monkeys, apes, and humans
resulted in an almost unique ability of this group of primates
to produce high antibody (Ab) titers against α-Gal (1). An
α1,3GalT gene (GGTA1) is also present in the human genome.
However, in human cells only truncated transcripts of this gene
have been detected. These transcripts lack the two catalytic
exons of galactosyltransferases and are thus translated in an
enzymatically inactive α1,3GalT polypeptide (2). Therefore,
humans cannot synthesize the α-Gal epitope. Instead, all non-
immunocompromised humans can develop a strong immune
response against this non-self-recognized oligosaccharide (3).
Abs directed against α-Gal are regarded as the only abundantly
expressed natural Abs in humans (3, 4). It has been suggested that
anti-α-Gal Abs are constantly produced in the gastrointestinal
tract against α-Gal epitopes present in the outer membrane
of bacteria from the intestinal microbiome (3). Owing to the
continuous antigen stimulation by the gut microbiome, also
a large number of blood B lymphocytes have the capability to
produce Abs directed against α-Gal (5–7). Most of these blood
B cells are memory B cells, but once foreign antigens expressing
α-Gal enter the body, these anti-α-Gal B cells are stimulated and
can produce large amounts of high-affinity α-Gal Abs (7, 8). Abs
raised against microbiome produced α-Gal have been described
to be IgM and IgG, predominantly IgG2. Indeed, IgG Abs to
carbohydrates are mostly IgG2 (9, 10).
The outcome of an immune response against foreign α-Gal
epitopes can be either beneficial or detrimental, depending on
the source of α-Gal and how and where the body encounters α-
Gal (11). A beneficial effect of anti-α-Gal Abs is the protection
against the transmission of vector-borne and non-vector-borne
pathogens that also carry α-Gal on their surface (6, 12). In
contrast, a negative effect of the immune response against α-Gal
is the rejection of xenotransplants, caused by the recognition of
α-Gal expressed on pig cells, which prevents the transplantation
of pig organs into humans (13). Another detrimental effect
of anti-α-Gal immunity is the α-Gal syndrome (AGS), which
is caused by IgE Abs directed against α-Gal and which is
characterized by two different forms of anaphylactic reactions:
delayed allergic reactions after ingestion of red meat and
immediate reactions in response to tick bites and during
intravenous exposure to cetuximab, a chimeric mouse-human
IgG1 monoclonal Ab (mAb) specific for the epidermal growth
factor receptor (EGFR) used in the treatment of colorectal
cancer (14–17).
In this manuscript, we reviewed our current knowledge and
hypothesis on the environmental, immune and molecular factors
associated with this recently discovered tick-related disease.
CLINICAL ASPECTS OF AGS
The term “syndrome” has recently been proposed to better
describe the clinical relevance of this unique allergy induced by
tick bites (18, 19). The distinctive clinical feature of AGS mainly
relates to a delay in the onset of systemic allergic reactions in
α-Gal sensitized individuals that typically occur 3–6 h after red
meat consumption, whichmakes the AGS different from all other
classical IgE-mediated food hypersensitivities (19, 20). However,
immediate anaphylaxis to tick bites and cetuximab has also
been reported (14–17). The mechanisms underlying the delay in
response to red meat consumption are still poorly understood,
but the factors involved in digestion, absorption and subsequent
presentation of α-Gal molecules to the host immune system after
red meat consumption appear to be very important (19, 21).
Specifically, delayed appearance of glycolipid forms of α-Gal in
blood circulation following the alterations in lipid and fatty acid
metabolism is a plausible explanation for the delay in symptoms
development (21). Moreover, in the same study Steinke et al. (21)
reported significant and time-dependent differences in baseline
expression of several metabolites between the healthy control
group and meat allergic subjects, with the highest disparity being
observed in amino acid/peptide and lipid metabolic pathways.
These findings further suggest that metabolic changes including
those related to amino acid catabolism, lipid, and carbohydrate
metabolism and bile acids synthesis are all associated with AGS
development and its presentation, likely through alterations of
components involved in the allergic response.
In general, AGS occurs in patients of all ages with no obvious
connection to a previous atopic disposition (22). However, there
are studies that described an impact of age and atopy on the
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development of AGS (23–25). Affected humans display a variety
of clinical symptoms and these commonly include urticaria,
pruritus, recurrent angioedema, or even life-threatening signs of
systemic anaphylaxis. Some individuals also described nausea,
diarrhea, indigestion, or abdominal pain prior to the onset of
the syndrome. Several patients with AGS report a complete
disappearance of the clinical symptoms, even after new exposure
to α-Gal, indicating the idiosyncratic nature of AGS (19, 20).
A recent study in forest workers with high exposure to tick
bites revealed sensitization against α-Gal in as many as 35% of
them, but AGS was diagnosed in <5% of the sensitized subjects
(25). These clinically distinct types of the syndrome presentations
suggest that allergen dose and/or co-factors may affect likelihood
and severity of the reaction (18, 26, 27). For instance, delayed
anaphylactic reactions to α-Gal are most frequently observed
after beef (53%) and pork (47%) consumption followed by
ingestion of lamb (9.1%) or deer (7.3%) meat (18). Moreover,
eating pork kidney and other mammalian innards often results
in a more severe and rapid reaction with clinical symptoms
appearing in <2 h after meat consumption (26, 28). Several
studies have revealed that pork kidney contains quantitatively
more α-Gal epitopes compared to muscle meat, indicating that
difference in severity and temporal dynamics of the anaphylaxis
in patients with AGS is closely associated with the amount of
accessible α-Gal determinants in the meat (18, 26, 29).
The way in which α-Gal is processed and absorbed after
ingestion of mammalian tissues is not yet well-defined (21).
Apart from the concentration of allergen ingested and individual
components involved in the modulation of the digestion
processes, some other factors may influence the risk of α-Gal-
sensitized individuals to develop an allergic reaction to red
meat (18, 30, 31). Concomitant alcohol consumption, physical
exercise and use of some type of medications (e.g., non-steroidal
anti-inflammatory drugs, acetylsalicylic acid) are associated with
variations in the clinical presentation of AGS, for instance
shorter delay of reactions in patients with IgE to α-Gal (23,
26, 28, 32). The general hypothesis is that these co-factors
increase gastrointestinal absorption and uptake of the allergen
by for example; increasing gastrointestinal permeability, blood
circulation, and histamine release (33). Therefore, AGS could
be classified as food-dependent exercise-induced anaphylaxis
(FDEIA) due to the striking effect of the modifying co-factors
on the timing of allergic reactions to meat as well as on the
presentation of α-Gal moieties to the patients’ immune system
(28). However, more in-depth studies are required to better
understand the effects of different co-factors and mechanisms
involved in the development and severity of AGS.
Aside from being involved in allergy to red meat, sensitization
to α-Gal is also associated with allergic reactions in individuals
exposed to different sources of α-Gal-containing antigens, other
than meat and meat by-products (19, 34). Immediate onset
anaphylaxis has been reported in patients with metastatic
colorectal cancer treated with cetuximab. Due to intravenous
infusion of the cancer drug containing high concentration
of α-Gal epitopes on the FAB portion of this molecule’s
heavy chain, reaction to cetuximab develops immediately and
may even be fatal in highly sensitized persons (15, 35).
Administration of vaccine and drugs containing mammalian
products such as gelatin, collagen or albumins, may also
confer a risk of the allergic reaction in individuals with anti-
α-Gal IgE Abs (34). Furthermore, results of recent studies
have shown that increased levels of IgE Abs to α-Gal have
been associated with premature degeneration of porcine aortic
valves (36) and increased atheroma burden and plaques,
which represents a potentially new risk factor for coronary
atherosclerosis (37). Finally, the AGS has been also associated
with anaphylactic reactions to tick bites, and the mechanisms
associated with these reactions have not been characterized
but likely include modulation of the immune response by
tick-derived molecules inoculated into the host during blood
feeding (17, 32).
AGS DIAGNOSIS AND PREVENTION
Diagnosis of AGS differs from that of typical food allergies
because of the delay in symptoms onset that usually occurs
a few hours after mammalian meat consumption. However,
the time of the symptoms appearance largely depends on the
allergen source (innards have higher potency compared tomuscle
meat) and several modifying co-factors (e.g., alcohol, exercise),
which shorten the time before reactions (18, 32). The unspecific
presentations of AGS including allergic reactions to tick bites
make the diagnosis very complex and challenging, therefore an
extensive patient’s history including all clinical aspects must be
taken into account before the laboratory tests are performed.
Currently, confirmation of the initial diagnosis involves skin
prick tests (SPT), determination of serum specific IgE Abs and
food challenges (38). Exposure of a patient’s skin to α-Gal-
containing extracts is a widely used diagnostic approach, but high
variations in sensitivity of the skin tests have been reported. In
particular, SPT using commercial meat extracts is found to be
unreliable as it generally yields poor or false negative results and
consequently leads to incorrect guidance for patients (39). Also,
SPT with native meat and meat products (prick-to-prick test)
usually yields false-negative or just weak skin reactions. Injection
of fresh pork or beef kidney preparations underneath the skin
(intradermal test) proved to be more sensitive when compared
to cooked or raw muscle meat from the same animal species
(28, 39), although this is not a feasible method to be used in
routine allergy diagnosis. Intradermal testing with 4% gelatin-
derived colloid (Gelafundin) provides an alternative test with
comparable sensitivity to skin test performed with fresh meat
products (40).
Commercially available assays for quantitative measurement
of serum IgE to α-Gal [threshold level >0.10 kUA/L, (31)] still
represent themost reliable diagnostic tool (20), but the diagnostic
value of the tests exclusively depends on the binding capacity
of antigen-specific IgE Abs (41). Determination of IgE levels
by using the abundantly α-Gal-decorated bovine thyroglobulin
showed to be more useful for diagnosis of AGS (100% sensitivity
and 92.3% specificity) in comparison to other IgE tests such
as α-Gal-biotin, beef, or pork (41). However, none of these
IgE tests can distinguish between individuals with AGS and
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those with asymptomatic α-Gal sensitization (38). Therefore, the
basophil activation test (BAT) has been proposed as an additional
in vitro diagnostic test, which may help to partially overcome
this limitation (38), although this test will be limited to few
specialized laboratories.
The food challenge is still considered as the gold standard
in food allergy diagnosis, but using this method in diagnosis
of the AGS is not recommended because of the delayed nature
of the reaction and also because it may cause a severe and
potentially fatal anaphylactic reaction (19). Complete avoidance
of mammalian meat, meat by-products, and other α-Gal-
containing foods is the only strategy proposed for preventing
recurrent episodes of allergic reactions in patients (20). Although
there is no strong evidence, many patients with α-Gal allergy
seem to be able to outgrow the hypersensitivity and tolerate
mammalian meat again either through prolonged tick bite
avoidance (1–2 years) or through continued exposure to very low
doses of α-Gal (19, 20, 42).
EPIDEMIOLOGY OF AGS
The first report of the capacity of ticks to induce red meat allergy
was in 2007 when van Nunen observed allergic reactions after red
meat consumption in 23 out of 25 patients, of which 24 reported
at least one tick bite (43, 44). Due to its recent discovery and
dissimilarities from most known food allergies, the reports on
the occurrence and distribution of AGS are strongly influenced
by the effort of individual research groups and clinicians. To the
best of our knowledge, no country has implemented a national
program to diagnose the AGS. In consequence, AGS is currently
underappreciated and underdiagnosed. AGS has been reported in
Australia, North America, Central and South America, Europe,
Asia and Africa (Table 1). Distribution of ticks expressing α-Gal
and human activities that favor exposure to tick bites seems to
shape the incidence of this disease worldwide. So far, tick bites
and therefore tick distribution and factors contributing to tick
bite exposure are the most relevant epidemiological elements
associated with AGS.
RISK FACTORS ASSOCIATED TO AGS
The knowledge of risk factors influencing the development of
AGS is still very limited, but important progress has been made
recently. In this regard, there is an important distinction to
be made, AGS patients have high anti-α-Gal IgE Ab levels
(43, 82, 83), but not all patients with high anti-α-Gal IgE
Ab levels develop AGS (25, 53, 74). Two major groups of
risk factors can be then distinguished: (i) those related with
social activities (e.g., employment as forest worker and hunting
activities) and ecological conditions (e.g., ground temperature
and relative humidity) that favor exposure to ticks and tick bites,
and (ii) others (e.g., blood type) that contribute to the capacity
of individuals to develop strong anti-α-Gal IgE response after
tick bites and therefore increase the probability to develop AGS.
Currently, it is not known whether these individual risk factors
are associated to specific genetic traits. In addition, as discussed




USA 5011 Amblyomma americanum (45–51)
Australia 801 Ixodes holocyclus
Ixodes (Endopalpiger) australiensis
(44, 52)
Sweden 95 Ixodes ricinus (53–55)
Japan 85 Haemaphysalis longicornis
Amblyomma testudinarium
(31, 56–59)
Germany 56 Ixodes ricinus (44, 60–62)
Spain 50 Rhipicephalus bursa (17, 32, 63)
Italy 27 Ixodes ricinus (31, 64–66)
France 24 (26, 44, 67–70)
Korea >12** Haemaphysalis longicornis (44, 71, 72)
Switzerland 6 Ixodes ricinus (73, 74)
Costa Rica 5 Amblyomma cajennense (44)
South Africa 5 (44, 75)
Panama 4 Amblyomma cajennense (31, 76)
Zimbabwe 1 (44)
Brazil 1 Amblyomma sculptum (31, 77)
Ivory Coast 1 Amblyomma variegatum (31, 78)
Norway 1 Ixodes ricinus (31, 79)
United Kingdom 1 (31, 80)
Netherlands 1 (81)
*A definitive association between these tick species and AGS has not been experimentally
proven in all these reports [see van Nunen (31)].
**The study by Sim et al. (72) reported 11 cases of AGS, Lee et al. (71) reported 1 case of
AGS and van Nunen (44) reported that several more cases of this disease have occurred
in Korea.
above, other factors including alcohol consumption, physical
exercise and use of some medications can affect the clinical
outcome of AGS. It is worth mentioning that no correlation
was found between age and sensitization to α-Gal in German,
Italian, and Spanish cohorts, whereas in a Danish group, older
individuals were found to be at higher risk to develop α-Gal
sensitization (23–25).
Ecological Risk Factors
It is currently accepted that α-Gal sensitization is induced
by tick bites and susceptible individuals develop AGS (23–
25, 44, 53). The relevance of tick bites to develop AGS is
further supported by the fact that some AGS patients were
able to tolerate the consumption of mammalian meat again
after preventing further tick bites (42). In consequence, the
distribution and abundance of ticks is a key factor to consider
when analyzing risk factors associated with AGS (31, 43, 44, 53,
82). In fact, one of the key clues on the causal role of tick bites
in the anaphylactic reactions induced by intravenous infusions
of cetuximab in southeastern United States was the overlap
between the region were cetuximab sensitivity and red meat
allergy were reported and the distribution of the lone star tick
Amblyomma americanum (15, 84, 85). An adequate knowledge of
the distribution of ticks is necessary to evaluate the risk they pose
to human health (86). In addition to A. americanum, other tick
species (e.g., Ixodes holocyclus, Ixodes ricinus, and Amblyomma
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sculptum, see also Table 1) have been associated with α-Gal
sensitization and AGS in different geographical regions (31).
The distribution of some of these tick species is rather big and
overdraws countries and even continents. Therefore, the sole
abundance of ticks in a given area is not sufficient to predict the
risk of α-Gal sensitization and AGS. A second important factor is
the actual exposure to tick bites.
As ectothermic organisms, the life cycle of ticks is deeply
influenced by the temperature. Ticks are sensitive to changes in
the ground temperature and relative humidity, which drive the
length of the life cycle and the mortality of the questing and
molting stages (87). The tolerated environmental thresholds are
species-specific: while a few tick species are plastic enough to
colonize a wide range of weather conditions, most others will
endure under narrower margins (88). The distribution of ticks
is influenced by several factors including vegetation, climate, and
habitat suitability for the main hosts of the tick (86). In exophilic
ticks (those that quest in the vegetation and do not live inside the
shelters of the hosts) the changes in climate are expected to exert
a deep influence, which has already been empirically observed
(89–93) or modeled (86, 94–96). The general pattern of spread
of the investigated ticks so far is an increase in both latitude
and altitude, matching the general trend to warmer autumn
and winter. The changing patterns of rainfall do not influence
the observed spread, probably because rain has little influence
on tick survival, relative humidity or saturation deficit are the
actual drivers of the tick’s mortality (97). This is of particular
interest for ticks that are known to be involved in AGS such as
A. americanum. Springer et al. (98) built a published summary
of collection records of A. americanum in USA and applied
present day and future climate scenarios to forecast the range
change of the tick. Future ensemble predictions for 2061–2080
forecasted minimum changes in the western range limit of the
tick, with a northward expansion of suitable climate into the
Upper Midwest and Western Pennsylvania. Results also pointed
to a range contraction along parts of the Gulf coast and the lower
Mississippi River valley.
In any case, patterns of distribution of ticks are also affected by
the small-scale availability of adequate patches of vegetation used
by suitable hosts for the tick, the tick itself, and frequently visited
by humans. This might explain why α-Gal sensitization and
AGS is more frequently reported in individuals from rural areas
compared to individuals from urban areas (24, 32). Additionally,
forest wardens, lumbermen and hunters, people with frequent
contact to ticks, are also commonly affected by this type of allergy
(23–25, 32). Consequently, German individuals from rural areas
or in forest-related jobs have 2.48 times higher risks of developing
α-Gal sensitization than the control group of a residential
population (24, 25). Similarly, it was found that Danish male
individuals with high tick exposure due to occupational and
hobbies reasons had a higher risk to have increased levels of
anti-α-Gal IgE Abs (23, 24). However, an association between
gender and anti-α-Gal IgE Abs could not be observed in other
cohorts from Germany and Spain (23, 25, 32), which pose
questions concerning the importance of gender differences in
the incidence of AGS. Alternatively, risk factors associated to
gender may be relevant only in the context of some countries
with specific alimentary habits or other factors yet to be identified
and characterized.
Some individuals with α-Gal sensitization and AGS, however,
do not recall having any recent tick bite (24). An explanation
for this finding might be that these individuals did not notice
the tick bite (24). The number of tick bites was also found to
influence the occurrence of α-Gal sensitization and AGS (24).
However, another study found no effect of the number of tick
bites during 1 year on the occurrence of α-Gal sensitization and
AGS (25). In contrast, the absence of tick bites reduced the anti-
α-Gal IgE levels in α-Gal-sensitized individuals suggesting that
tick seasonality might influence the frequency of occurrence of
AGS (84). The idea of AGS seasonality was supported by the fact
that the anti-α-Gal IgE levels decreased over the winter (when the
questing activity of ticks is very low) in a cohort of forest service
employees in Germany (25).
Individual Risk Factors
Atopy
Atopic allergy is type I hypersensitivity that occurs in individuals
with intense IgE-mediated immune responses after exposure to
allergens such as mites, dander, food, or other substances that
are otherwise innocuous. Some studies reported an association
between atopy (diagnosed by SPT) and anti-α-Gal IgE positivity
(23–25). The increase in anti-α-Gal IgE levels correlates with
that of the total IgE and therefore atopy was postulated as an
important predisposing factor to develop AGS (25). In another
study, however, no correlation was found between AGS and a
previous atopic disposition (22).
ABO Blood Groups
The structure of the α-Gal epitope is similar to that of the
blood group B antigen of the ABO blood group system (10, 83).
The only difference between the blood group B and the α-Gal
epitope is that the former has a fucose residue, absent in α-
Gal. Individuals of blood groups AB and B produce the type
B antigen in their red blood cells (RBC), whereas the RBCs
of individuals of blood groups A and O lack this antigen.
Several studies reported that individuals with blood groups AB
and B are significantly underrepresented among AGS patients
(10, 41, 53, 83). In addition, individuals of blood groups AB
and B produce less anti-α-Gal IgE Abs than those produced
by individuals lacking antigen B in their blood groups with
implications for the development of AGS (10, 41, 53). In fact,
a recent report shows that type B antigen confers protection
against the development of AGS (41). One study, however, did
not find a significant association between different ABO blood
groups and the anti-α-Gal IgE levels (25). It is worth mentioning
that in the study by Fischer et al. (25) sera and not RBCs were
used to identify the blood group of the patients. Identification
of blood groups using sera is not very precise. One hypothesis
explaining the protective role of type B antigen in AGS is that
individuals of blood groups AB and B are tolerant to this antigen
and do not develop a strong immunity against the self-type B
antigen and the related antigen α-Gal (99). In agreement with
this hypothesis, low levels of anti-antigen B Abs in blood group
B individuals were associated with low levels of anti-α-Gal IgE
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Abs (10). Despite strong evidence of the protective role of blood
groups AB and B in the development of AGS, the blood type is
frequently overlooked in epidemiological studies of AGS (100).
Evidence suggests that individuals of blood groups A and O may
have higher risk to develop AGS compared to individuals with
blood groups AB and B.
Other Risk Factors
The α-Gal epitope can be also found on cat IgA, IgM and
cat dander (23, 101, 102). Therefore, the possible association
between cat IgA, IgM, cat dander and α-Gal sensitization in
cat owners has been studied (23, 25). The possible association
between pet ownership, especially cats, and α-Gal sensitization
and AGS has not yet been fully elucidated. For example, while
some groups did not find any significant AGS risk related to
cat ownership (25), others observed a high correlation between
cat ownership and increased levels of anti-α-Gal IgE (23). An
airborne-triggered α-Gal sensitization due to cat dander was
ruled out (23, 74). In addition, anti-α-Gal IgE positivity was
not linked to cat allergy analyzed by SPT. Therefore, the cause
of the association of cat ownership and elevated specific anti-
α-Gal IgE remains obscure and possible explanations include
cat scratches as a route of sensitization or introduction of
ticks to human settlements by the cats. Additionally, some pet-
associated endoparasites (e.g., Toxocara spp.) were proposed to
potentially induce, beside tick bites, α-Gal sensitization in pet
owners (23, 103). Although the role of intestinal roundworms
of pets spilling over to humans could not be confirmed by
using serum antibodies against the helminths in a Spanish
cohort, the capacity of intestinal roundworms to induce α-
Gal sensitization in human should be considered in future
studies (23).
ORIGIN OF TICK α-GAL
It is still a matter of debate how tick bites initiate the anti-
α-Gal IgE response, whether the response is triggered by tick-
derived α-Gal present in tick salivary proteins, or by mammalian
glycoproteins or glycolipids that remained in the tick from a
previous blood meal or by α-Gal expressed by other organisms,
such as protozoan parasites, bacteria or viruses, that are
transmitted by ticks. However, recent studies indicated that the
anti-α-Gal IgE response is most likely caused by tick-derived α-
Gal. Firstly, Hamsten et al. (54) visualized in immunolocalization
experiments the α-Gal epitope in the gastrointestinal tract of I.
ricinus ticks. Then, Araujo et al. (104) provided evidence for
the presence of this epitope in the saliva of A. sculptum ticks
by ELISA and immunoblotting (104). These authors further
observed the capacity of the saliva-derived α-Gal epitope to
induce an anti-α-Gal IgE Ab response in α-galactosyltransferase
knockout mice either by injection of tick saliva or by tick
bites (104). In another study, Mateos-Hernández et al. (17)
showed the presence of tick proteins containing the α-Gal
modification in Rhipicephalus microplus BME/CTVM23 cells and
Hyalomma marginatum salivary glands. The molecular basis of
endogenous synthesis of α-Gal in ticks was then demonstrated
by the identification of three α-galactosyltransferase genes in
the genome of the black-legged tick Ixodes scapularis (105).
Heterologous gene expression in α-Gal-negative cells and gene
knockdown in ticks showed that these genes are indeed involved
in α-Gal synthesis and that they are essential for tick feeding
and play an important role in tick-pathogen interactions (105).
N-linked glycan analysis and immunolocalization confirmed
the presence of α-Gal in the salivary secretory vesicles of A.
americanum and I. scapularis fed with human blood, which lacks
α-Gal. Furthermore, salivary samples from these ticks were able
to activate basophils primed with plasma from α-Gal allergic
patients (106).
All these findings indicate that tick-derived α-Gal triggers
the development of α-Gal allergy. The tick-borne pathogen
Anaplasma phagocytophilum increased the levels of α-Gal in
infected tick cells suggesting that tick-borne pathogen infection
may increase α-Gal levels in ticks in vivo (105). This finding
has influenced our current way of thinking about tick-pathogen
interaction since the consequences of tick infestation is not only
related to transmission of pathogens to animals and/or humans,
but also the increased ability of infected ticks to induce AGS
in humans.
IMMUNITY TO TICK BITES AND AGS
The pathomechanism of the AGS is poorly understood. Still
the question remains, why and how the transmission of the
α-Gal epitope during a tick bite can induce an α-Gal-specific
IgE response and in which way defense mechanisms initiated
in the body contribute to the development of this response.
The tick-host interface is characterized by complex interactions
between the host and the arthropod. As soon as mouthparts
of the tick first disrupt the epidermis and then enter the
dermis, host immune mechanisms are initiated in the skin.
The injury caused by the intrusion of tick mouthparts into
the skin triggers in the host hemostatic responses, such as
coagulation, vasoconstriction, and platelet aggregation (107).
Besides, also humoral and cellular components of the innate
immune system are activated such as the complement system,
keratinocytes, endothelial cells, and different leukocytes, which
release anti-microbial peptides and pro-inflammatory cytokines
and chemokines leading to the recruitment of neutrophils and
other inflammatory cells (108). Subsequently, components of
the adaptive immune system contribute to the inflammatory
response against ticks such as memory T and B cells that are
activated and release specific cytokines or produce Abs against
tick antigens (107).
Mouthparts of the tick enter the dermis after disrupting
the epidermis. In the process of wound healing, a subtype
of macrophages, the M2 macrophages, is involved (109). M2
polarized macrophages have the ability to suppress inflammation
via upregulation of anti-inflammatory cytokines, such as
interleukin (IL) 10 or transforming growth factor beta (TGF-β)
to protect the host from detrimental effects of an excessive Th1
response. Additionally, tick saliva has the capacity of inhibiting
the production of proinflammatory cytokines such as IL-1 in
macrophages (108). In this way, tick saliva might also boost the
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effect of M2 macrophages. Inhibition of a Th1 immune response
would in turn, skew the immune response toward Th2.
Mice successively infested by ticks showed augmented levels
of TGF-β together with gradually increasing levels of IL-10 and
IL-4 after every exposure to ticks (110). This finding suggests that
by upregulation of Th2 cytokines, tick bites skew the polarization
of the immune response toward a more anti-inflammatory Th2
cell profile that suppresses a Th1 response (108). However,
Th2 immune responses induce the production of Abs of the
IgE isotype and could therefore participate in the development
of AGS.
Looking at the tick’s perspective, the defense responses of the
host can cause pain, itch, blood flow disruption in the feeding
cavity, or direct damage to the tick (107), and are consequently a
hindrance for effective blood feeding. Therefore, ticks developed
multiple evasion strategies to counteract them. Tick saliva
contains a highly complex mixture of immunomodulatory
substances (108), which inhibit the mechanisms of hemostasis
and suppress innate and adaptive host immune responses. Ticks
differentially produce some of these substances during blood
feeding (111). Compounds present in the tick saliva are able to
reduce the production of pro-inflammatory cytokines such as IL-
12, IL-1β or Tumor necrosis factor alpha (TNF-α) (107), and
at the same time increase the production of anti-inflammatory
mediators like TGF-β or IL-10 (110) that might also contribute
to the generation of a Th2 response.
Prostaglandins are among the most abundant bioactive
molecules in tick saliva (112). Prostaglandin E2 (PGE2), present
in high concentrations in tick saliva, induces vasodilation, and
reduces inflammation (112). PGE2 impairs wound healing by
reducing fibroblast migration, while mediating an increased
migration of macrophages, which in turn are induced to secrete
more PGE2 (113). The hallmark of allergic diseases is the
production of IgE Abs. It has been shown that PGE2 induces class
switch recombination on B cells, leading to the production in
vivo of IgE Abs (114). It can thus be speculated that tick salivary
PGE2 might also stimulate a class switch to IgE Abs in anti-α-
Gal B cells. In this context, it is interesting to note that defense
mechanisms against parasites such as helminths are characterized
by Th2 responses with elevated levels of IgE Abs that seem to
have a protective function in these infections (115). However,
it has been hypothesized that IgE Abs might be important for
immune responses to environmental toxins such as venoms (116)
and in fact, toxins are present in the saliva from a number of
different tick species (117, 118). In patients suffering from AGS
high levels of specific anti-α-Gal IgE Abs are accompanied by
high levels of α-Gal-specific IgG1 Abs. Elevated IgG1 Abs have
been observed to confer immune resistance to cutaneous feeding
by ticks in guinea pigs (119). However, IgG1 Abs did not seem
to have IgE-blocking activity and could not prevent anaphylactic
reactions (120).
In summary, tick bites might induce allergic reactions to
proteins present in the tick’s saliva. In fact, anaphylactic reactions
to tick proteins have been reported in several regions including
Australia (44, 121) and Europe (122), among others. However,
it is not yet known which exact mechanisms are behind
the production of anti-α-Gal IgE Abs. Two hypotheses were
proposed (99). The first hypothesis suggests that in the context
of Th2 cell-mediated immunity induced by tick saliva, α-
Gal expressed on tick saliva proteins is presented to antigen-
presenting cells (APCs) and B cells, which would trigger the
differentiation of B cells into plasma cells producing anti-α-Gal
IgE Abs. The second hypothesis suggests that tick saliva contains
factors, like PGE2, that could induce class switch recombination
of pre-existing B cell clones producing anti-α-Gal IgM and/or
IgG to produce IgE.
ROLE OF HUMAN IMMUNE CELLS IN AGS
Dendritic cells (DCs) represent a major link between the innate
and the adaptive immune system since they have typical innate
immune receptors, but they are also able to function as antigen
presenting cells (APCs) for activation of adaptive immune
responses. In the skin and in mucosal tissues, immature DCs
recognize and phagocytose antigens. Owing to a concomitant
activation of pattern recognition receptors, DCs mature and
migrate to the draining regional lymph nodes. There they present
the processed antigens in the cleft of major histocompatibility
complex (MHC)I or MHCII molecules to T cells, which then
initiate an adaptive immune response (123).
The way of internalization and processing of antigens
determines whether an antigen is considered as harmless or
as dangerous by the body. Ristivojević et al. (124) showed in
in vitro experiments in immature monocyte-derived dendritic
cells (iMDDCs) that the uptake of bovine serum albumin (BSA)
increased substantially when the protein was glycosylated and
carried α-Gal moieties on the surface. Furthermore, the presence
of α-Gal also affected the degradation pathway of BSA since
α-Gal carrying BSA was slower degraded than BSA without α-
Gal (124). This suggests that α-Gal, but not the protein carrying
the oligosaccharide, is recognized by the DCs as an antigen and
affects the uptake and processing of the protein. The fact that
it has been shown that bioactive components such as PGE2
present in the tick saliva can polarize the cytokine production
of DCs toward a Th2 phenotype (125) might suggest that the
IgE response against α-Gal is caused solely by the interaction
between DCs and components of the tick saliva. However, since it
is known that DCs do not produce cytokines essential for Th2 cell
differentiation (such as IL-4), the interplay between the tick saliva
and the host immune system apparently requires other factors for
the induction of an anti-α-Gal Th2 response (126).
Mast cells play a central role in the pathogenesis of allergic
diseases. They are tissue-resident granulocytes and express FcεRI,
a high-affinity Fc receptor specific for the ε heavy chains of IgE
Abs. Upon activation by cross-linking of FcεRI-bound IgE Abs,
mast cells degranulate and release various mediators including
enzymes like tryptase or chymase, cytokines also including the
Th2 cytokines IL-4 and IL-13 (127), and biogenic amines such
as histamine that cause the typical symptoms of allergic diseases.
In contrast, the relevance of mast cells in the immune response
to ticks is still not understood. Mast cell numbers do not change
after a primary tick infestation but the number of mast cells rises
after subsequent tick infestations (128). This might explain why
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IL−4 levels in mice were found to increase only after repeated
infestations by ticks (110). Furthermore, ticks can either promote
the secretion of histamine via a histamine release factor (129)
or counteract the effects of secreted histamine by producing
histamine-binding lipocalins (130, 131). These findings point
to the ambiguous role of mast cells in the interplay between
ticks and the host’s immune system. So far studies investigating
the importance of mast cells in the development of the α-Gal
syndrome are missing.
Basophils are granulocytes circulating in the blood. Like mast
cells, they also express the high-affinity IgE receptor FcεRI,
degranulate upon activation and release histamine, and other
mediators. Basophils play an important role in chronic allergic
inflammation and in protective immunity against parasites
(126). It is known that in the immune response against
ticks, basophils are recruited to the tick-feeding site during
a second tick infestation, to accumulate in the skin and
play an important role as tick rejection factors (132, 133).
In guinea pigs, resistance to tick infestation was associated
with basophils infiltration at the tick feeding site and IgG1
Abs appeared to play a role in the basophil response to
ticks (119). Patients with AGS show, together with IgE Abs
to α-Gal, higher titers of IgG1 to this oligosaccharide than
healthy individuals (120). Remarkably, basophils might also be
involved in the initiation of Th2 immune responses since it
has been shown in mouse models that they can act as non-
professional antigen presenting cells (APC) and produce IL-
4. In this way, basophils were able to induce epicutaneous
Th2 sensitization to food antigens applied on skin lesions,
and promote the development of IgE-mediated food allergy in
mice (126, 134). It could be speculated that in a similar way
basophils could eventually also participate in the initiation of
the allergic response against α-Gal. There the injury caused by
the tick mouthparts in the skin could initiate the recruitment of
basophils which by secretion of IL-4 might trigger a Th2 response
against α-Gal.
TRADE-OFF BETWEEN AGS AND
PROTECTION TO PATHOGENS
Ticks are haematophagous ectoparasites of vertebrates and
besides causing AGS, ticks transmit a wide variety of pathogens
including bacteria, viruses, protozoa, and helminths (135). In
particular, Lyme disease caused by the spirochete Borrelia
burgdorferi is the most common tick-borne disease in temperate
regions of North America, Europe, and Asia, and the number
of reported cases has increased in the last years (136). For
example, this disease is of public health concern in France
where the average incidence is 47/100 000 and in some regions
it can reach 200/100 000 (137). Anti-α-Gal immunity is a
good model to understand the association between allergy
and vector-borne pathogen transmission. Gut bacteria induce
IgM and IgG anti-α-Gal Abs that are widely produced in
humans (4), and at high levels these Igs protect against malaria
transmission by Anopheles mosquitoes (6). Furthermore, α-
Gal immunization protects against Chagas disease (138) and
leishmaniasis (139). The anti-α-Gal Ab response may also protect
against infection by other non-vector-borne pathogens such
as Mycobacterium spp. causing different forms of tuberculosis
and mycobacteriosis (140). All pathogens producing these
diseases have the α-Gal epitope exposed on their surface (6,
138–140). Evidence from our lab suggests that B. burgdorferi
expresses α-Gal on their surface. This finding suggests that
anti-α-Gal IgM and IgG may protect against several pathogens
expressing α-Gal on their surface. In contrast to gut microbiota,
α-Gal in tick salivary glycoproteins induces a significant
increase in the levels of anti-α-Gal IgE in the human host
leading, as discussed in this review, to AGS. These results
suggest that while IgM and IgG to α-Gal can be protective
against some pathogens, IgE α-Gal might instead promote
harmful allergies.
Immunity to α-Gal provides a goodmodel to study howAbs to
α-Gal might promote allergy and/or protection against pathogen
infection and transmission by vectors. Evidence suggests that
individuals with blood type B produce fewer anti-α-Gal IgE Abs,
and that AGS is strongly associated with blood type B negative
individuals (10, 53, 141). The reduced capacity of blood group
B individuals to produce anti-α-Gal Abs is presumably due to
tolerance to α-Gal, which is similar to blood group B antigen
(10). In agreement with the negative effect of blood group B
on anti-α-Gal immunity, it was recently discovered that the
frequency of blood group B is positively correlated with the
incidence of malaria and tuberculosis in endemic regions (140).
Interestingly, Lyme disease patients do not develop high anti-
α-Gal IgE when compared to AGS patients (53), even though
both group of patients (i.e., Lyme disease and AGS) should have
been equally exposed to tick bites. High anti-α-Gal IgE in AGS
patients correlates with high anti-α-Gal IgG (10). An interesting
hypothesis emerges: AGS patients who are blood group B
negative may produce high levels of anti-α-Gal IgG and IgM
which may protect them from Lyme disease and other diseases
caused by α-Gal-containing pathogens. Hence, a strong immune
response to α-Gal may protect against these diseases with the
trade-off of developing AGS (11). Despite these observations,
the relation between AGS and pathogen infection/transmission
has never been experimentally tested. Understanding the balance
between these two immune responses to α-Gal may lead to
interventions to control both AGS and infectious diseases.
CONCLUSIONS AND
FUTURE DIRECTIONS
The AGS is a recently reported disease present in many parts
of the world and associated with tick infestations. The IgE Ab
response against α-Gal is the triggering response leading to
AGS but the molecules and immune mechanisms behind it are
still to be discovered. The characterization of these molecules
and mechanisms is essential to improve AGS diagnosis and to
develop interventions for the prevention and control of this
disease. Future research should be focused on the identification
of tick proteins involved in the production of anti-α-Gal IgE
Abs after a tick bite and the immune mechanisms leading to
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AGS. The relationship between tick species and AGS applying
Koch’s postulates in animal models would contribute to better
understand disease cause and evaluation of epidemiological risks.
Data on blood group type should be included in epidemiological
studies to better evaluate the risks associated with blood type
in the population. Other factors that may affect the AGS such
as endoparasite infections and microbiota composition in both
humans and ticks should be considered. Finally, the possibility of
using the anti-α-Gal IgM and IgG Ab responses for the control
of infectious diseases caused by pathogens with α-Gal on their
surface should be developed and could contribute to controlling
some of the most prevalent and mortal diseases in the world.
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